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URL: http://www.itqb.unl.pt/pbfs (C.M. Gomes).The electron transfer ﬂavoprotein (ETF) is a hub interacting with at least 11 mitochondrial ﬂavoen-
zymes and linking them to the respiratory chain. Here we report the effect of the ETFa-T/I171 poly-
morphism on protein conformation and kinetic stability under thermal stress. Although variants
have comparable thermodynamic stabilities, kinetically their behavior is rather distinct as ETFa-
T171 displays increased susceptibility to cofactor ﬂavin adenine dinucleotide (FAD) loss and
enhanced kinetics of inactivation during thermal stress. Mimicking a fever episode yields substan-
tial activity loss. However, the presence of substoichiometric concentrations of GroEL is sufﬁcient to
act as an effective buffer against long-term thermal denaturation. Our investigations are compatible
with the notion that the ETFa-T171 variant displays an altered conformational landscape that
results in reduced protein function under thermal stress.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Single amino acid polymorphisms (SAP’s) are non-synonymous
genetic variations in coding regions that occur in more than 1% of
a population and are sometimes simplistically considered as ‘neu-
tral variants’. On the other hand, it is well known that these so
called neutral SAP’s can contribute to the manifestation and
severity of disease phenotypes. With the current DNA sequencing
technologies and genome-wide association studies a tremendous
number of SAP’s has been identiﬁed and possible associations
with disease phenotypes have been suggested. This is in sharp
contrast to functional and mechanistic understanding of the
subtle effects such amino acid replacements may have and how
they transform into modulation of organismal phenotypes. Inchemical Societies. Published by E
n; SAP’s, single amino acid
MP, adenosine 50monophos-
iency; CD, circular dichroism;
ública 127, 2780-756 Oeiras,cases where SAPs are involved in a disease state, it is therefore
important to characterize their effects, namely on kinetics of
thermal denaturation processes so that proper therapies and
preventive measures could be implemented to minimize disease
manifestation.
In the present study we have explored molecular effects of a
speciﬁc SAP in the alpha subunit of human electron transfer ﬂavo-
protein (ETF). ETF is a key enzyme for mitochondrial energy metab-
olism as it receives electrons from at least 11 dehydrogenases
operating in fatty acid oxidation, amino acid and choline metabo-
lism. The reducing power gained in these oxidation reactions is
transferred via ETF and its partner ETF:ubiquinone oxidoreductase
(ETF:QO), the terminal membrane-bound enzyme of this pathway
[1,2], to the respiratory chain via ubiquinone. ETF is a heterodimer
composed of a 30 kDa a-subunit (ETFa) and a 28 kDa b-subunit
(ETFb). It contains one ﬂavin adenine dinucleotide (FAD) as redox
cofactor, and one structural adenosine 50monophosphate (AMP)
that is essential for the assembly of the dimer [3]. A special prop-
erty of ETF is that, in the interaction with its partner acyl-CoA
dehydrogenases, it undergoes extensive domain movement and
conformational changes enabling its FAD domain to sample confor-
mations compatible with fast electron transfer [4].
Many inborn errors of metabolism result from defects in com-
ponents of this pathway and deleterious mutations in the geneslsevier B.V. All rights reserved.
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acyl-CoA dehydrogenase deﬁciency (MADD, OMIM # 231680) [5].
The SAP studied in the present work results in incorporation of a
threonine (T) or an isoleucine (I) at position 171 of the ETFa poly-
peptide. This SAP has earlier been investigated experimentally by
heterologous prokaryotic expression [6] and it has been shown
that the ETFa-T171 variant had a decreased enzymatic stability.
Assessment of the frequency of this SAP in a control group and var-
ious patient groups associated with fatty acid oxidation disorders
showed that patients with the mild form of very long chain acyl-
CoA dehydrogenase deﬁciency (VLCADD) [7] had a signiﬁcant over-
representation of the ETFa-T171 variant [6]. Although only a small
number of patients was analysed, this suggested that the ETFa-
T171 might modulate the phenotype by an as yet unknown mech-
anism [6]. Therefore a detailed study on the conformational and ki-
netic stability of this SAP and of the effect of heat stress on enzyme
activity is mandatory. Moreover, the rescue of the destabilized
forms by molecular chaperones can be an evidence of the role of
chaperones on protein homeostasis, with potential therapeutic
application.
2. Materials and methods
2.1. Chemicals
All reagents were of the highest purity grade commercially
available. Octanoyl-CoA, and FAD were purchased from Sigma. Iso-
propyl-b-D-thiogalactopyranoside (IPTG) was purchased from VWR
International.2.2. Gene expression and protein puriﬁcation
Escherichia coli JM109 cells transformed with the ETF plasmids,
ETFa-Ile171 and ETFa-Thr171, respectively [6], were grown in LB
(Luria–Bertani) supplemented with 10 lg ml1 kanamycin at
37 C in a shaking incubator until OD532 of 0.5–0.8 was reached.
The cells were then induced with 1 mM IPTG for 4 h. Cells were
harvested by centrifugation, re-suspended in 10 mM Hepes, 10%
ethylene glycol and 0.5 mM phenylmethylsulphonylﬂuoride
(Roth), pH 7.8 (buffer A) in presence of DNase (PVL) and
disrupted in a French press. The soluble extract was applied to
a Q-Sepharose fast ﬂow (GE Healthcare, 20 ml) equilibrated in
buffer A. The column was washed with 5 volumes of buffer A,
and bound proteins were eluted by a linear gradient from 0 to
1 M NaCl, in buffer A. Pure ETF eluted at around 250 mM
salt, and purity was conﬁrmed by SDS–PAGE. Protein concentra-
tion was determined using the Bradford assay. Flavin content
was determined using the molar extinction coefﬁcient
e436nm = 13 400 M1 cm1 reported for FAD bound to ETF [8]. Pure
ETF fractions with a 2.5-fold molar excess FAD were fast-frozen
using liquid nitrogen and stored at 80 C.2.3. GroEL expression and puriﬁcation
The E. coli chaperonin, GroEL was isolated and puriﬁed as de-
scribed earlier [9]. Brieﬂy, the GroEL was puriﬁed using an Afﬁ-
Gel Blue treatment, after which the samples were precipitated
in 45% (V/V) acetone at room temperature for 5 min. The precip-
itate was centrifuged at 10,000g for 30 min and, after the re-
moval of acetone, re-suspended in buffer. Residual protein
aggregates and acetone were removed by a brief centrifugation
followed by an extensive dialysis. Protein purity was conﬁrmed
by the second derivative analysis of the absorbance spectra
showing the lack of contributions from tryptophan and secondar-
ily by SDS–PAGE.2.4. Activity assays
ETF enzyme activity was measured following 2,6-dichlorophe-
nol indophenol (DCPIP) reduction at 600 nm in a coupled assay
in which recombinant human MCAD (Medium Chain Acyl-CoA
Dehydrogenase) and octanoyl-CoA were employed, as described
in [10]. One unit of catalytic activity is deﬁned as nmol of DCPIP re-
duced per minute, in the conditions used in the assay. All speciﬁc
activities reported are based on total ﬂavin content.
2.5. Spectroscopic methods
Before each experiment FAD excess added to buffers as a preser-
vative was removed by extensive washing using ultraﬁltration/
dilution, and all experiments were performed with pure proteins
containing full occupancy of FAD site. UV/visible spectra were re-
corded at room temperature in a Shimadzu UVPC-1601 spectrom-
eter with cell stirring. Fluorescence spectroscopy was performed
using a Cary Eclipse instrument. For aromatic emission excitation
wavelength was set at 280 nm, and FAD emission was followed
setting excitation wavelength at 436 nm; slits were 5 and 10 nm
for excitation and emission, respectively. Typically protein concen-
tration was 1 lM. Circular dichroism (CD) spectra were recorded
on a Jasco J-815 spectropolarimeter with a cell holder thermostat-
ically controlled with a Peltier. A quartz polarized 1 mm or 10 mm
path length quartz cuvettes (Hellma) was used, and protein con-
centrations were typically 0.1 or 1.0 mg ml1, for far-UV and
near-UV measurements, respectively.
2.6. Thermal stability
Thermal unfolding with a linear temperature increase was fol-
lowed using CD (ellipticity variation at 222 nm and 288 nm) and
ﬂuorescence spectroscopy, tryptophan emission (kex = 280 nm;
kem = 340 nm), FADemission (kex = 436 nm; kem = 530 nm)and FRET
from tryptophan emission to FAD cofactor (kex = 280 nm;
kem = 530 nm). In general a heating rate of 1 C min1 was used,
and temperature was increased from 30 to 90 C. Heating rates in
the range of 0.5–2 C min1 were also tested using Far-UV CD. For
the analysis of the thermal inactivation proﬁles of the enzyme activ-
ity, samples were incubated for 10 min at different temperatures
(from30 to75 C).Datawereanalysedaccording toa two-statemod-
el, and ﬁts to the transition curves were made using OriginPro8.
2.7. Kinetics of ﬂavin release
ETF variants 1 lM were incubated at different temperatures
(39, 45, 50 and 55 C) for up to 60 min in 10 mM Hepes, pH 7.8.
The kinetics of ﬂavin release were monitored from the increase
of the 530 nm emission peak arising from free FAD upon excitation
at 436 nm. After 1 h of incubation the samples were boiled for
5 min, to release the remaining FAD and a spectrum was collected
at 25 C. The fraction of bound FAD was determined at each point
in respect to the point of 100% release of FAD.
2.8. Kinetics of thermal inactivation
ETF (8 lM) in 10 mM Hepes pH 7.8, was incubated at 39 C up
to 120 min and the residual activity was determined in relation
to the activity at time zero (duplicate measurements were pre-
formed for each time point). The experiment was repeated in pres-
ence of 1.7 lM GroEL oligomer (10 mM Hepes, 1 mM ATP, 15 mM
KCl, 5 mMMgCl2, pH 7.8). A control with BSA instead of GroEL was
made in order to distinguish unspeciﬁc effects. BSA concentration
was 24 lM as the concentration of GroEL monomer, and the buffer
contained also ATP, KCl and MgCl2.
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3.1. Effect of the ETFa-T/I171 variation on the conformational stability
ETF is composed of three structural domains: domain I and II
are formed by the N- and C-terminal portions of the a subunit,
respectively, while domain III is formed by the b subunit [3]. The
polymorphic position ETFa-171 is located in domain I at the inter-
face with domain II (Fig. 1). The isoleucine (I) or threonine (T) at
this position has thus contacts with a set of side chains from the
three nearby hydrophobic residues: Ile 269, Val 270 and Ala 271.
The effect of the polymorphic variation at this interfacial position
on protein stability was investigated from thermal melting exper-
iments. Protein unfolding was monitored as a function of temper-
ature using a combination of biophysical methods: far-UV CD for
monitoring secondary structure changes, near-UV CD and trypto-
phan ﬂuorescence to monitor tertiary interactions and FAD ﬂuores-
cence to report on cofactor contacts. The data obtained showed
that all these probes reported the same midpoint of thermal dena-
turation (midpoint transition temperature, Tm = 58 C) for the two
variants (Fig. 2A). Further investigation revealed that the melting
temperature is not signiﬁcantly dependent on the heating rate.
Also, there were no differences between the spectra of native prep-
arations of the variants, in any of the spectroscopic techniques
used, and both variants presented an enzymatic activity of
1200 U min1. This indicates that the alternation between an iso-
leucine and a threonine at the ETFa-171 position does not affect
the fold or the thermal stability of ETF.
3.2. Thermal inactivation proﬁles
A previous study had shown that in an assay with octanoyl-CoA
and MCAD as electron donor the electron transfer activity of the
ETFa-T171 variant is more susceptible to thermal inactivation than
the ETFa-I171 variant [6]. However, the molecular origins of this
different behavior were not further addressed. This ﬁnding appears
to contradict our present data, which show that both variants have
the same midpoint of thermal denaturation. We have therefore
reinvestigated this and corroborate the earlier ﬁndings with our
preparations of the ETF variant proteins: upon incubation at differ-
ent temperatures for 10 min, the ETFa-T171 activity decays at low-
er temperatures than that of ETFa-I171 (Fig. 2B). ETF is a protein
known to undergo extensive sampling of conformations of the
FAD-containing domain – an ‘induced disorder’ mechanism – when
bound to the partner dehydrogenase. Some of the conformationsFAD
Fig. 1. Structural model of human electron transfer ﬂavoprotein. This cartoon highlights
gray (domain I), grey (domain II), and dark grey (domain III), the interactions of positio
PyMOL, on the basis of PDB coordinates 1efv.are compatible with fast electron transfer from the dehydrogenase
[4,11,12]. Therefore, the observed discrepancy between the ther-
mal denaturation and activity proﬁles suggests that the ETFa-I/
T171 polymorphism may inﬂuence the dynamic properties of the
protein upon thermal perturbation, as opposed to the overall sta-
bility of the protein as suggested for other enzymes [13].
3.3. ETFa-T171 has a decreased kinetic stability upon thermal
perturbation
In order to gain further insight into the structural changes
occurring during thermal perturbation of the two ETF variants,
the kinetics of thermal perturbation were determined under differ-
ent conditions of thermal stress. Changes in protein folding were
evaluated using ﬂuorescence spectroscopy of the FAD-environ-
ment as a probe for structural changes. The dissociation rate of
the cofactor was monitored at conditions of increasing thermal
stress: 39, 45, 50 and 55 C. The results obtained showed that the
two variants differ in kinetic stability, as the rates of FAD release
during thermal perturbation by ETFa-T171 were always higher
than those observed for ETFa-I171 and the difference between
the variants increases with temperature (Fig. 3). Thus, the ETFa-
T171 variant is more prone to undergo temperature-driven confor-
mational transitions that result in FAD release at temperatures
well below the midpoint temperature for thermal unfolding.
3.4. Activity decay under physiological thermal stress
Fatty acid oxidation deﬁciency phenotypes are known to be
triggered or exacerbated by stress factors such as fever [14]. Fol-
lowing the ﬁnding that the polymorphic variation at ETFa-171
modulates the kinetics of destabilization under thermal stress,
we have investigated if this effect would be noticeable under con-
ditions mimicking a fever episode. For this purpose, we have incu-
bated the two variants at 39 C for up to 120 min, with periodic
sampling for activity measurements. In agreement with the previ-
ous results we have observed that the ETFa-T171 has an increased
susceptibility towards thermal inactivation, in comparison to
ETFa-I171 (Fig. 4). Throughout the thermal perturbation assay,
the activity of the ETFa-I171 variant was always higher, and the
relative decrease in activity was only 15%, whereas 50% of the
ETFa-T171 was lost during this physiological thermal stress. This
result suggests that due to this higher kinetic instability ETFa-
T171 variant may decrease electron ﬂux from dehydrogenases to
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Fig. 2. Thermal stability (A) and thermal inactivation (B) of ETF variants. (A) The thermal unfolding curves for ETFa-Ile171 (s) and ETFa-Thr171 (j) were determined
monitoring ETF unfolding using far-UV CD and aromatic ﬂuorescence emission. Both techniques yielded the same results but for clarity purposes only the normalized
variation of the CD singal at 222 nm is shown. Although ETF is a dimeric protein, its thermal unfolding can be described by a two-state process, as shown by the solid sigmoid
curve (see Section 2 for details). The protein concentration used was 1.7 lM, in 2 mM Hepes, pH 7.8. (B) The thermal inactivation of the ETF activity was monitored for the
ETFa-Ile171 (s) and ETFa-Thr171 (j) variants up to 75 C. The plot represents the residual activity upon 10 min incubation at the different temperatures tested (see Section












































Fig. 3. Kinetics of ﬂavin release. (A) ETFa-Ile171 (s) and ETFa-Thr171 (h) were incubated in 10 mM Hepes, pH 7.8 at 55 C and ﬂavin release was followed monitoring
increase in ﬂuorescence emission at 530 nm upon excitation at 436 nm. (B) Plot of the observed kinetic rates for ﬂavin release at 39 C, 45 C, 50 C and 55 C, according to a
ﬁrst order process (ETFa-Ile171 dark grey bars and ETFa-Thr171 light grey bars).
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thermal stress
As already stated above heat stress results in a deterioration of
mitochondrial b-oxidation in cultured ﬁbroblasts obtained from
patients with fatty acid oxidation disorders [14]. Our ﬁndings on
the increased kinetic instability of ETFa-T171 upon thermal stress
suggests that this variation broadens the conformational space of
ETF, especially the FAD binding domain, resulting in the sampling
of more inactive conformations. If this is the case, then we might
expect that conformations with increased kinetic instability could
be rescued by molecular chaperones. We have tested this possibil-
ity using GroEL, which binds to partially folded proteins in solution
and then uses the energy of ATP hydrolysis to drive the protein to a
folding-competent state [15]. In this experiment we measured the
residual activity of ETFa-T171 during incubation at 39 C, in the
presence and absence of substoichiometric concentrations ofGroEL oligomer (5ETF:1GroEL) and excess ATP (Fig. 5). Strikingly,
the results obtained showed that a substiochiometric concentra-
tion of activated (i.e., ATP/ADP bound) GroEL is rather efﬁcient in
rescuing the conformational destabilization during thermal stress:
after 120 min of incubation at 39 C the protein still had 95% of
its original activity when GroEL was present, whereas in its ab-
sence the activity has decayed to 50%. A control experiment for
unspeciﬁc interactions was carried out, in which BSA in the pres-
ence of ATP was added to the assay resulting in a decay comparable
with the one observed in the absence of GroEL, thus showing the
speciﬁcity of the effect. The same experiment was also carried
out using the ETFa-I171 variant, and the results obtained show
that in this case the presence of GroEL has almost no effect, in
agreement with the fact that the ETFa-I171 polymorphism has a
higher kinetic stability upon thermal stress (Fig. S1). Clearly, the
distinct partitioning of the two variants into GroEL shows that, un-
der thermal stress, the polymorphic position modulates kinetics. In





















Fig. 4. Kinetic proﬁle of ETFa-Ile171 (j) and ETFa-Thr171 (s) thermal inactivation.
Each protein sample was incubated for 120 min at 39 C, samples were taken at
different time points and the remaining catalytic activity was determined (see
Experimental Procedures). Two independent replicates were assayed, and each
point represents the average of two experiments obtained with different protein
batches (standard errors less than 5%).





















Fig. 5. Substoichiometric concentrations of activated GroEL prevents heat inacti-
vation for ETFa-Thr171. Time dependent thermal inactivation proﬁle of 8 lM ETFa-
Thr171 in presence (d) and absence (s) of 1.7 lM GroEL oligomer. Protein was
incubated for 120 min at 39 C, samples were taken at different time points and the
remaining catalytic activity was determined (see Experimental Procedures). Two
independent replicates were assayed, and each point represents the average of two
experiments obtained with different protein batches (standard errors less than 5%).
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inactivation during thermal stress has been described for several
protein model systems, such as dihydrofolate reductase but in this
case, the GroEL concentration exceeded the DHFR concentration (3
GroEL oligomer to 1 DHFR) [16].
4. Discussion
Thermal stress is an important modulator of disease in mito-
chondrial beta oxidation disorders and disease-causing missense
mutations that affect protein stability or activity are particularly
susceptible to this effect [17–21]. In recent years, important pro-
gress has been made in the understanding of the molecular and
structural basis of point mutations affecting different fatty acid
oxidation enzymes, including ETF and ETF:QO [22,23]. However,
the molecular effects of polymorphic protein variations in humandisease remain poorly understood. That is for example the case of
the ApoE4 variant which plays a role in multiple disease [24], and
of the polymorphic variation in the PrP protein that acts as a
molecular switch in the control of interspecies disease transmis-
sion [25]. These examples clearly show that polymorphic varia-
tions may play a key role in the modulation of the biological
function, by mechanisms which remain to be addressed at the
protein-molecular level. Focusing on the effects of the polymor-
phic variation Isoleucine/Threonine at ETFa-171, we have shown
that it affects the kinetic behavior upon thermal stress, and that
the ETFa-T171 variant is kinetically destabilized. ETF is reported
to be a highly dynamic protein in solution as well as when it
forms a complex with it’s co-partners [26]. Domain II, which
accommodates the FAD cofactor, was shown to rotate upon com-
plex formation with partner acyl-CoA dehydrogenases thus bring-
ing the FAD bearing moieties in contact in order to allow electron
transfer to occur [27]. The dynamics of this domain induces a
sampling of more ﬂexible conformations that induce a disorder
mechanism that leads to complex formation with the partner
dehydrogenases [4]. Interestingly, the polymorphic position ana-
lysed is within domain I, in close contact to domain II. One may
speculate, on the basis of the available crystal structures, that
replacement of isoleucine with a threonine at position 171 in
ETFa may inﬂuence the dynamics of ETF in the following way:
an isoleucine would favor hydrophobic contacts with nearby ali-
phatic side chains from domain II (Fig. 1), whereas a threonine
occupying this position would be less effective and would thus
make the regions more ﬂexible. A very interesting correlation of
our observations with clinical data arises from the fact that the
ETFa-T171 is overrepresented among patients suffering from a
mild form of VLCAD deﬁciency. This ﬁnding suggests that
this polymorphism could eventually account for an increased
susceptibility to inactivate ETF upon cell stress. This is commonly
observed in metabolic diseases in which metabolic decompensa-
tion is intertwined with mitochondrial dysfunction resulting from
metabolite accumulation, oxidative stress or fever. Although we
have shown that molecular chaperones can rescue these destabi-
lized conformations and restore activity to higher levels, their
overload as a result of massive proteostasis challenges may hin-
der complete recovery in patients. In agreement with this it has
been recently reported that fever impairs beta oxidation in ﬁbro-
blasts from patients suffering from different mitochondrial fatty
acid beta oxidation defects [14]. The analysis of additional poly-
morphic variations, and demonstration that molecular chaperones
provide a transient kinetic buffer against heat denaturation, may
be important in preventing stress induced denaturation of poly-
morphic variants. As interest in therapeutic upregulation of the
heat stress proteins grows, it is crucial to demonstrate that main-
taining higher levels of background chaperone buffer effects are
valid approaches toward reducing the deleterious effects of heat
stress within individuals carrying subtle temperature sensitive
mutations.
Acknowledgements
The work was supported by the Fundação para a Ciência e Tecn-
ologia (FCT/MCTES, Portugal): Research Grant PTDC/SAU-GMG/
70033/2006 (to C.M.G), and fellowship SFRH/BD/29200/2006 (to
B.J.H.). IAMI Kaufmann grant (to M.T.F.). The Alfred Benzon Foun-
dation is acknowledged for an interchange grant.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.01.002.
510 B.J. Henriques et al. / FEBS Letters 585 (2011) 505–510References
[1] Olsen, R.K. et al. (2007) ETFDH mutations as a major cause of riboﬂavin-
responsive multiple acyl-CoA dehydrogenation deﬁciency. Brain 130, 2045–
2054.
[2] Ghisla, S. and Thorpe, C. (2004) Acyl-CoA dehydrogenases. Eur. J. Biochem. 271,
494–508.
[3] Roberts, D.L., Frerman, F.E. and Kim, J.J. (1996) Three-dimensional structure of
human electron transfer ﬂavoprotein to 2.1-A resolution. Proc. Natl. Acad. Sci.
USA 93, 14355–14360.
[4] Toogood, H.S., van Thiel, A., Basran, J., Sutcliffe, M.J., Scrutton, N.S. and Leys, D.
(2004) Extensive domain motion and electron transfer in the human electron
transferring ﬂavoproteinmedium chain acyl-CoA dehydrogenase complex. J.
Biol. Chem. 279, 32904–32912.
[5] Frerman, F.E., Goodman, S.I., Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D.,
Childs, B., Kinzler, K.W. and Vogelstein, B. (2001) Defects of electron transfer
ﬂavoprotein and electron transfer ﬂavoprotein–ubiquinone oxidoreductase:
glutaric acidemia type II in: The Metabolic and Molecular Basis of Inherited
Disease (Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Childs, B., Kinzler, K.W.
and Vogelstein, B., Eds.), 8th ed, pp. 2357–2365, McGrawHill, New York.
[6] Bross, P. et al. (1999) A polymorphic variant in the human electron transfer
ﬂavoprotein alpha-chain (alpha-T171) displays decreased thermal stability
and is overrepresented in very-long-chain acyl-CoA dehydrogenase-deﬁcient
patients with mild childhood presentation. Mol. Genet. Metab. 67, 138–147.
[7] Andresen, B.S. et al. (1999) Clear correlation of genotype with disease
phenotype in very-long-chain acyl-CoA dehydrogenase deﬁciency. Am. J.
Hum. Genet. 64, 479–494.
[8] McKean, M.C., Beckmann, J.D. and Frerman, F.E. (1983) Subunit structure of
electron transfer ﬂavoprotein. J. Biol. Chem. 258, 1866–1870.
[9] Voziyan, P.A. and Fisher, M.T. (2000) Chaperonin-assisted folding of glutamine
synthetase under nonpermissive conditions: off-pathway aggregation
propensity does not determine the co-chaperonin requirement. Protein Sci.
9, 2405–2412.
[10] Rhead, W., Roettger, V., Marshall, T. and Amendt, B. (1993) Multiple acyl-
coenzyme A dehydrogenation disorder responsive to riboﬂavin: substrate
oxidation, ﬂavin metabolism, and ﬂavoenzyme activities in ﬁbroblasts.
Pediatr. Res. 33, 129–135.
[11] Craig, D.H., Barna, T., Moody, P.C., Bruce, N.C., Chapman, S.K., Munro, A.W. and
Scrutton, N.S. (2001) Effects of environment on ﬂavin reactivity in
morphinone reductase: analysis of enzymes displaying differential charge
near the N-1 atom and C-2 carbonyl region of the active-site ﬂavin. Biochem. J.
359, 315–323.
[12] Toogood, H.S., van Thiel, A., Scrutton, N.S. and Leys, D. (2005) Stabilization of
non-productive conformations underpins rapid electron transfer to electron-
transferring ﬂavoprotein. J. Biol. Chem. 280, 30361–30366.
[13] Tsou, C.L. (1998) Active site ﬂexibility in enzyme catalysis. Ann. N. Y. Acad. Sci.
864, 1–8.[14] Li, H., Fukuda, S., Hasegawa, Y., Purevsuren, J., Kobayashi, H., Mushimoto, Y.
and Yamaguchi, S. (2010) Heat stress deteriorates mitochondrial beta-
oxidation of long-chain fatty acids in cultured ﬁbroblasts with fatty acid
beta-oxidation disorders. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
878, 1669–1672.
[15] Hartl, F.U. and Hayer-Hartl, M. (2009) Converging concepts of protein folding
in vitro and in vivo. Nat. Struct. Mol. Biol. 16, 574–581.
[16] Martin, J., Horwich, A.L. and Hartl, F.U. (1992) Prevention of protein
denaturation under heat stress by the chaperonin Hsp60. Science 258, 995–
998.
[17] Olsen, R.K., Andresen, B.S., Christensen, E., Bross, P., Skovby, F. and Gregersen,
N. (2003) Clear relationship between ETF/ETFDH genotype and phenotype in
patients with multiple acyl-CoA dehydrogenation deﬁciency. Hum. Mutat. 22,
12–23.
[18] Andresen, B.S. et al. (1997) The molecular basis of medium-chain acyl-CoA
dehydrogenase (MCAD) deﬁciency in compound heterozygous patients: is
there correlation between genotype and phenotype? Hum. Mol. Genet. 6,
695–707.
[19] Bross, P. et al. (1995) Effects of two mutations detected in medium chain acyl-
CoA dehydrogenase (MCAD)-deﬁcient patients on folding, oligomer assembly,
and stability of MCAD enzyme. J. Biol. Chem. 270, 10284–10290.
[20] Corydon, T.J. et al. (1998) Rapid degradation of short-chain acyl-CoA
dehydrogenase variants with temperature-sensitive folding defects occurs
after import into mitochondria. J. Biol. Chem. 273, 13065–13071.
[21] Pedersen, C.B., Bross, P., Winter, V.S., Corydon, T.J., Bolund, L., Bartlett, K.,
Vockley, J. and Gregersen, N. (2003) Misfolding, degradation, and aggregation
of variant proteins: the molecular pathogenesis of short chain acyl-CoA
dehydrogenase (SCAD) deﬁciency. J. Biol. Chem. 278, 47449–47458.
[22] Gregersen, N., Andresen, B.S., Pedersen, C.B., Olsen, R.K., Corydon, T.J. and
Bross, P. (2008) Mitochondrial fatty acid oxidation defects – remaining
challenges. J. Inherit. Metab. Dis. 31, 643–657.
[23] Maier, E.M. et al. (2009) Protein misfolding is the molecular mechanism
underlying MCADD identiﬁed in newborn screening. Hum. Mol. Genet. 18,
1612–1623.
[24] Zhong, N., Ramaswamy, G. and Weisgraber, K.H. (2009) Apolipoprotein E4
domain interaction induces endoplasmic reticulum stress and impairs
astrocyte function. J. Biol. Chem. 284, 27273–27280.
[25] Sigurdson, C.J. et al. (2010) A molecular switch controls interspecies prion
disease transmission in mice. J. Clin. Invest. 120, 2590–2599.
[26] Burgess, S.G., Messiha, H.L., Katona, G., Rigby, S.E., Leys, D. and Scrutton, N.S.
(2008) Probing the dynamic interface between trimethylamine
dehydrogenase (TMADH) and electron transferring ﬂavoprotein (ETF) in the
TMADH-2ETF complex: role of the Arg-alpha237 (ETF) and Tyr-442 (TMADH)
residue pair. Biochemistry 47, 5168–5181.
[27] Chohan, K.K., Jones, M., Grossmann, J.G., Frerman, F.E., Scrutton, N.S. and
Sutcliffe, M.J. (2001) Protein dynamics enhance electronic coupling in electron
transfer complexes. J. Biol. Chem. 276, 34142–34147.
